Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targetsCarsten Müller-Tidow, Joachim Schwäble, Björn Steffen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarraysKlaus H Metzeler, Annika Dufour, Tobias Benthaus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcomeAnnika Dufour, Friederike Schneider, Klaus H Metzeler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupJürgen Krauter, Katharina Wagner, Irina Schäfer, et al.Haematologica|May 13, 2014
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapseMax Hubmann, Thomas Köhnke, Eva Hoster, et al.Genes, Chromosomes & Cancer|January 1, 2003
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemiaAndreas Reiter, Susanne Saussele, David Grimwade, et al.Annals of Hematology|February 25, 2012
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patientsAnnika Dufour, Friederike Schneider, Eva Hoster, et al.Molecular Cancer Therapeutics|December 19, 2006
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptorsEmma Kulimova, Elisabeth Oelmann, Guido Bisping, et al.Haematologica|July 30, 2016
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single centerMichele Pohlen, Julia Marx, Alexander Mellmann, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2016
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias]Ute Kossak-Roth, Susanne Saußele, Carlo Aul, et al.Pageof 9